🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "focused measures to deal with household expense issues" in the upcoming Budget.

During an interview with media outlets, she stated that reducing inflation is a collective duty of both the administration and the central bank.

The UK's inflation rate is forecast to be the highest among the G7 developed nations this calendar year and next.

Potential Utility Bill Interventions

Reports indicate the administration could take action to reduce utility costs, for example by reducing the present 5% level of VAT charged on energy.

Another approach is to cut some of the government charges presently included in bills.

Fiscal Constraints and Expert Expectations

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for these actions.

The consensus from the majority of economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to fulfill her voluntary fiscal targets.

Earlier on Thursday, analysis suggested there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a shared responsibility between the central bank and the government to further reduce some of the causes of inflation," the Chancellor informed the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and International Concerns

While much of the attention has been on expected tax rises, the Treasury chief said the most recent figures from the OBR had not altered her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with rising international and commercial concerns for the Budget tax moves, likely to be directed on those "most able to pay."

International Economic Disputes

Commenting on concerns about the United Kingdom's commercial links with the Asian nation she said: "Our national security always take priority."

Last week's statement by China to strengthen trade restrictions on critical minerals and other materials that are key for advanced tech production led US President Donald Trump to threaten an extra 100% import tax on goods from China, increasing the possibility of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary called China's action "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and causes additional challenges."

"I believe there are sectors where we need to address Chinese policies, but there are also significant opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also affirmed she was working with international partners "on our own critical minerals plan, so that we are more independent."

NHS Drug Costs and Investment

Reeves also admitted that the price the National Health Service pays for drugs could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either pausing or abandoning investments in the United Kingdom, with several blaming the insufficient payments they are getting.

Recently, the Science Minister said the cost the health service spends on drugs would must rise to halt businesses and drug research funding departing from the United Kingdom.

Reeves stated to the BBC: "We have seen because of the payment system, that clinical trials, new drugs have not been offered in the United Kingdom in the manner that they are in other EU nations."

"Our aim is to make sure that individuals receiving treatment from the National Health Service are able to receive the top critical treatments in the globe. And so we are reviewing this situation, and... looking to secure increased capital into Britain."